Filing Details

Accession Number:
0001388658-20-000050
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-03-16 20:19:39
Reporting Period:
2020-03-12
Accepted Time:
2020-03-16 20:19:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1388658 Irhythm Technologies Inc. IRTC () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1385014 M Kevin King C/O Irhythm Technologies, Inc.
699 8Th St # 600
San Francisco CA 94103
President And Ceo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-03-12 14,778 $4.00 244,290 No 4 M Direct
Common Stock Disposition 2020-03-12 576 $81.20 243,714 No 4 S Direct
Common Stock Disposition 2020-03-12 14,202 $80.21 229,512 No 4 S Direct
Common Stock Acquisiton 2020-03-13 4,218 $4.00 233,730 No 4 M Direct
Common Stock Disposition 2020-03-13 4,218 $80.00 229,512 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2020-03-12 14,778 $0.00 14,778 $4.00
Common Stock Employee Stock Option (right to buy) Disposition 2020-03-13 4,218 $0.00 4,218 $4.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
6,495 2024-07-10 No 4 M Direct
2,277 2024-07-10 No 4 M Direct
Footnotes
  1. The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 20, 2019.
  2. Weighted average from multiple transactions with prices ranging from $80.00 to $80.45. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares purchased at each separate price.
  3. All of the shares subject to this option are fully vested and exercisable as of the date hereof.